{"name":"Magenta Therapeutics, Inc.","slug":"magenta-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE96RHh4QkZmWVpoUEVVQTNoMElQR09NbXBJUkhFdlZEVlZzbUtYZnBpTHg2andwOUNaci1KaHowLXV4c3dlTXBLT0pSaldfNFN6WXpVemZ30gFbQVVfeXFMTkZlLVhDX1dvVzUtTEd6UENKajBhSFBONV8yZlprNHhVSzluWDJQS1RPYW5iSzBfSzdVNkhLbGZTcEdvZzlXbl9hcGFBVnZXUkhrXzFGLUJiVnpBYw?oc=5","date":"2026-02-01","type":"pipeline","source":"BioInformant","summary":"Pivotal Trends Impacting the Global Cord Blood and Tissue Industry in 2025 - BioInformant","headline":"Pivotal Trends Impacting the Global Cord Blood and Tissue Industry in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQTm9qRFRSdjNtTWdKS0gwMkIwT2R4eGF3OFBnN0tDMHg4MFBYc0tYV0hOYUluUVhieWRLdTktNTNYZjRaQVJ6eEtBV3hYeERtMnV0ZUZZelNDdHZxQk83b08takttQjlDREVFWnVFODJlWTVPU2lCMzFjS1Yxc2FwZTJCZzVVWVFZLXV4NXRJMjNvY2RSMmhvQXdFM0tCVFVEQVRtV1AzT0NlT0pVWktiZkUyV2VaVWFzcE1ZcXlTd1d4QkZEZWFBazgzM1JIVWEwaWlmQ3JqREloZ0puYm5HVUR4SkQ3RTZkTUdSLWJCeWJJd0YzenpUcVZGNGc5c0QtdWhqaDQ2clFrakU?oc=5","date":"2025-12-19","type":"pipeline","source":"Finansavisen","summary":"Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - Finansavisen","headline":"Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPMlFTaV93TU9Ga2R4M1U2SUxwTnlwNlJmUkRVaUN2aExjWlpEV0k2TFVrVDU5VWxmUzhLdlFKZDZWZkYzNUp4NW5GNFN5NFZZTnRaVlljaXdXMzdRc3EwSVY1WnctUW9xeFlmS25nMjdGNWE4WjZBLWFrblYycFdrZVI1YUxuR3Zw?oc=5","date":"2025-07-08","type":"pipeline","source":"The Pharma Letter","summary":"Crescent brings in Jan Pinkas as CSO - The Pharma Letter","headline":"Crescent brings in Jan Pinkas as CSO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNcHdoMEtka0tIVURMZjBLSFVCQWZHYkxQTHFOTXZhUTNlVm01ekxfanVySS1YRlVETmNJX2N1NE45SmxqcVp0NktpNXZSOTJ5cGNxX2NoeHlTZnhyUE5rMzNwa1JlSkVDMlhyWFdvRGFiV3JUTkNkQVk1dmVGX19SMzlCQ0pzMHpIYTM2ZG9wZFpiSVh2OUd1Tw?oc=5","date":"2025-06-02","type":"pipeline","source":"Yahoo Finance","summary":"Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer - Yahoo Finance","headline":"Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOUlRJWERWWHR2ZVJ6MTZrZ282a3ZVVHR4T2M4OE5hc1BHYzVfODVoMUxmVkU4NUR4RExhUTBsNWVEY2E0akxzOHBQREQ5UGlMQmpmdWFWTlEyLTVzcTd3dFdRYnVBVy1UMGJwekdLaV82enU0LWVyRGNyVlMwMmZRaURn?oc=5","date":"2025-04-18","type":"pipeline","source":"INDmoney","summary":"Magenta Therapeutics Inc (DNTH) Live Share Price, Invest From India - INDmoney","headline":"Magenta Therapeutics Inc (DNTH) Live Share Price, Invest From India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNcmh0WjU3U2ZiTXlaRk12Q1ZrdXNpRTM3OVBoWWYxUTlZNzhWNXBWYmFvblVjaVRpTXpsakl5dTd6LTlmSzBWZWdwTmtqVnRhbXZQYUtzZHU2UEtORFh0WGllb19QX0s4STRnOFNoYm11VkpMRGNTUzAwak16cWktXzhIMVFMV2kzd0RkbVYwVGVNcDh4d05DLU5sZW5iS1hNRWlNUg?oc=5","date":"2023-11-03","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Longtime BioMarin CEO hands baton off to Genentech chief - Fierce Biotech","headline":"Chutes & Ladders—Longtime BioMarin CEO hands baton off to Genentech chief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOb29DRWhWdmhILTRzcjFUX2tteWtBX2l1Ty00bzFscUxDU0RoLU5JOG9KUExGSkc4akRId3NiLWY4SWZZcWpZZk9qUjVzMUR2ellTcXlUWi12Q1dicWgtWEdSdDBiVUJmS1E4dThia2FBeW5PaVEwcFRGeEV6aGVfYlU4TE03OEJCQkhYTjhnWmU4T3JhOTNOWjdOYjlnQlZR?oc=5","date":"2023-08-14","type":"pipeline","source":"The Business Journals","summary":"CEO of shuttered biotech Magenta Therapeutics makes leap to Flagship startup - The Business Journals","headline":"CEO of shuttered biotech Magenta Therapeutics makes leap to Flagship startup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNUjQtTWZ3bDZJaEhXN1A4RVNBWEZLcENrOGs0ZEZuUG5tVU05TGpYV1FlN3lFbmdQdF9yanJZaXdRZlZrQnZGbVlhSVJRam04RTF1cVV0VUoxb0tLV21rRWhpZ2h3eGhOUkQ0dnZJTHAyZW5LNlFZcUxudzVwWEo0TVhnUHpsd0NWVEczZU9OZFhzYWdCWjUwVXAycFV3ampBakZIclZFckdFMVlTUWlMOWxJZm1WczRGY0ZlR2lxcENwdEx0Zmp3?oc=5","date":"2023-05-04","type":"deal","source":"Medical Marketing and Media","summary":"Magenta and Dianthus unveil merger, creating next-gen autoimmune therapeutics powerhouse - Medical Marketing and Media","headline":"Magenta and Dianthus unveil merger, creating next-gen autoimmune therapeutics powerhouse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNQVJXSHktWm5mNHRLckNzYmZhdFFvV1BBa2pQRHpBRG9ZZGdsaFp6bkpmSGUzT3k5N1ZPVV9fcFlLTUFZOHFUVjZWankzSWNQeHpNYWMxWjkzNXVzU3lfeUtLamljNmNOZUY2OUh3TldWblpmU3pjbzJHbXdBdURpMlNveV9qUE8tUkE?oc=5","date":"2023-05-03","type":"deal","source":"BioPharma Dive","summary":"Magenta agrees to reverse merger with Dianthus after setbacks - BioPharma Dive","headline":"Magenta agrees to reverse merger with Dianthus after setbacks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQYVhHNTBNckR6NFJLeVZ0RnJwTHpETlhYSy1OclFVT1pGNWo0LXJjZ05vUzFGeVBmNndMMmNlaXcydmFZSFN2ZlJsdl9MOEViU05Scm16bVpjVkppQVI2dXB2N1NoZXFmZjVkdGJDUHpEZXdJZkJMaEFYZWZPY1lqZ0xlOEVCM0tKQ09VaGpuTEw1bnpoaThHamRFR2dKbERLdDVaMHNZWTJ0d0EtWVJOMXhyLWlrMW1pVFY2RXc2ZUk0UktLUDQ4R2tnb0dpajEzRmJQbGNDZV9iSzZ2?oc=5","date":"2023-05-03","type":"deal","source":"GlobeNewswire","summary":"Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement - GlobeNewswire","headline":"Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPRjFjTEd0TDZLWG5wQ2tONVV3NUIzX1BjVEZ2SVVvcEFwQVBYX0R2b1BaWVNuOGw0WXY3WGRtZXpiS1R4VVQ4dEl5Xzk2TTFHWkMxX04wTGpYbzY4R0thLVZyT3BMS2EyUXV2cF9XWkVSQ3VUSThna3pQd0RzdjhUZ0Q1bmdiXzVyZ25QREREcEYyOGR5TTFNS3J3?oc=5","date":"2023-01-26","type":"trial","source":"BioPharma Dive","summary":"Magenta halts study of targeted conditioning drug after participant’s death - BioPharma Dive","headline":"Magenta halts study of targeted conditioning drug after participant’s death","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2020-12-04","type":"trial","source":"Business Wire","summary":"Magenta Therapeutics and bluebird bio Announce a Phase 2 Clinical Trial Collaboration to Evaluate Magenta’s MGTA-145 for Mobilizing and Collecting Stem Cells in Adults and Adolescents with Sickle Cell","headline":"Magenta Therapeutics and bluebird bio Announce a Phase 2 Clinical Trial Collaboration to Evaluate Magenta’s MGTA-145 for","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}